Characterization of Non–Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment Patterns

PURPOSE: MET exon 14 (METex14) skipping alterations are oncogenic drivers in non–small-cell lung cancer (NSCLC). We present a comprehensive overview of METex14 samples from 1,592 patients with NSCLC, associated clinicogenomic characteristics, potential mechanisms of acquired resistance, treatment pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jessica K., Madison, Russell, Classon, Anthony, Gjoerup, Ole, Rosenzweig, Mark, Frampton, Garrett M., Alexander, Brian M., Oxnard, Geoffrey R., Venstrom, Jeffrey M., Awad, Mark M., Schrock, Alexa B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407654/
https://www.ncbi.nlm.nih.gov/pubmed/34476332
http://dx.doi.org/10.1200/PO.21.00122

Ejemplares similares

Ejemplares similares